CARA THERAPEUTICS
Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and pruritis. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.
CARA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2004-07-02
Address:
Shelton, Connecticut, United States
Country:
United States
Website Url:
http://www.caratherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
+1 203 567 1503
Email Addresses:
[email protected]
Total Funding:
472.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Devon Park BioVentures
Devon Park BioVentures investment in Series D - Cara Therapeutics
Mitsubishi Corporation
Mitsubishi Corporation investment in Series D - Cara Therapeutics
MVM Life Science Partners
MVM Life Science Partners investment in Series D - Cara Therapeutics
Connecticut Innovations
Connecticut Innovations investment in Series D - Cara Therapeutics
Scottish Widows Investment Partnership
Scottish Widows Investment Partnership investment in Series D - Cara Therapeutics
Ascent Biomedical Ventures
Ascent Biomedical Ventures investment in Series D - Cara Therapeutics
Alta Partners
Alta Partners investment in Series D - Cara Therapeutics
Rho Capital Partners
Rho Capital Partners investment in Series D - Cara Therapeutics
Connecticut Innovations
Connecticut Innovations investment in Series C - Cara Therapeutics
Devon Park BioVentures
Devon Park BioVentures investment in Series C - Cara Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-03 | Cara Therapeutics Announces CEO Transition |
Official Site Inspections
http://www.caratherapeutics.com Semrush global rank: 4.84 M Semrush visits lastest month: 1.85 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
